Tanshinol B
Reference standards.
Inquire / Order:
manager@chemfaces.com
Technical Inquiries:
service@chemfaces.com
Tel:
+86-27-84237783
Fax:
+86-27-84254680
Address:
1 Building, No. 83, CheCheng Rd., Wuhan Economic and Technological Development Zone, Wuhan, Hubei 430056, PRC
Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to
24 months(2-8C).
Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.
Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com
The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
Planta Med.2018, 84(15):1101-1109
Kangwon National University2022, 37(1):29-37
Clin Transl Med.2021, 11(5):e392.
Appl. Sci.2020, 10(4),1304
Mol Biol Rep.2023, 50(5):4029-4038.
Biomed Pharmacother.2023, 166:115329.
Evid Based Complement Alternat Med.2018, 2018:4259603
Antimicrob Agents Chemother.2020, AAC.01921-20.
Institute of Food Science & Technology2021, 18 December.
Inflammation.2022, 45(6):2529-2543.
Related and Featured Products
Organic & Biomolecular Chemistry, 2018, 16.
Total synthesis of (±)-tanshinol B, tanshinone I, and (±)-tanshindiol B and C.[Reference:
WebLink]
METHODS AND RESULTS:
A concise and efficient approach was established for the divergent total synthesis of (±)-tanshindiol B and C and tanshinone I from a ubiquitous ene intermediate in 1-2 steps. This critical intermediate was derived from (±)-Tanshinol B, which was synthesized in 50% overall yield over 3 steps using an ultrasound-promoted cycloaddition as a key step. Compared to a previously reported strategy, our approach is more step-economic, thus greatly improving the synthetic efficiency.
CONCLUSIONS:
The bioactivity evaluation indicates that the diol stereochemistry of the tanshidiols has an impact on the EZH2 inhibitory activity.
